In yesterday’s Wall Street session, Cardlytics Inc. (NASDAQ:CDLX) shares traded at $13.50, up 19.79% from the previous session.
3 analysts cover Cardlytics Inc. (NASDAQ:CDLX), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $19.00 and a low of $9.00, we find $15.00. Given the previous closing price of $11.27, this indicates a potential upside of 33.1 percent. CDLX stock price is now 92.52% away from the 50-day moving average and 125.21% away from the 200-day moving average. The market capitalization of the company currently stands at $400.27M.
The stock has received a hold rating from 2 analysts and a buy rating from 1. Brokers who have rated the stock have averaged $14.33 as their price target over the next twelve months.
With the price target reduced from $14 to $13, Wells Fargo Downgraded its rating from Equal Weight to Underweight for Cardlytics Inc. (NASDAQ: CDLX).
In other news, Christiansen Andrew, Chief Financial Officer sold 13,404 shares of the company’s stock on Jul 19. The stock was sold for $136,721 at an average price of $10.20. Upon completion of the transaction, the Chief Financial Officer now directly owns 70,775 shares in the company, valued at $0.96 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jul 03, Chief Executive Officer Temsamani Karim Saad sold 25,574 shares of the business’s stock. A total of $156,666 was realized by selling the stock at an average price of $6.13. This leaves the insider owning 24,426 shares of the company worth $0.33 million. Insiders disposed of 70,062 shares of company stock worth roughly $0.95 million over the past 1 year. A total of 2.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in CDLX stock. A new stake in Cardlytics Inc. shares was purchased by POTOMAC CAPITAL MANAGEMENT, INC. during the first quarter worth $2,390,000. ALPHACREST CAPITAL MANAGEMENT LLC invested $854,000 in shares of CDLX during the first quarter. In the first quarter, EMPOWER ADVISORY GROUP, LLC acquired a new stake in Cardlytics Inc. valued at approximately $532,000. ERGOTELES LLC acquired a new stake in CDLX for approximately $380,000. KENT LAKE CAPITAL LLC purchased a new stake in CDLX valued at around $364,000 in the second quarter.
On Wednesday morning Cardlytics Inc. (NASDAQ: CDLX) stock kicked off with the opening price of $13.76. During the past 12 months, Cardlytics Inc. has had a low of $2.57 and a high of $18.21. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 1.30, and a quick ratio of 1.30. The fifty day moving average price for CDLX is $7.18 and a two-hundred day moving average price translates $6.02 for the stock.
According to the Advertising Agencies Company, earnings per share came in at -$0.24, beating analysts’ expectations of -$0.35 by 0.11. This compares to -$3.75 EPS in the same period last year. The company reported revenue of $76.7 million for the quarter, compared to $75.41 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 1.72 percent. For the current quarter, analysts expect CDLX to generate $77.66M in revenue.
